Nanologica AB (publ) reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was SEK 5.83 million compared to SEK 14.72 million a year ago. Net loss was SEK 55.23 million compared to SEK 44.83 million a year ago.

Basic loss per share from continuing operations was SEK 1.84 compared to SEK 1.6 a year ago.